Filing Details
- Accession Number:
- 0001209191-20-063921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 20:25:07
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-16 20:25:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1294133 | Inogen Inc | INGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1596080 | Alison Bauerlein | C/O Inogen, Inc. 326 Bollay Drive Goleta CA 93117 | Evp, Finance, & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-15 | 8,702 | $16.62 | 11,017 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 4,449 | $39.44 | 6,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-15 | 1,904 | $40.42 | 4,664 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-15 | 2,349 | $41.33 | 2,315 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-15 | 8,702 | $0.00 | 8,702 | $16.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-31 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.
- Represents the weighted average share price of an aggregate total of 4,449 shares sold in the price range of $39.01 to $39.92 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 1,904 shares sold in the price range of $40.18 to $40.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 2,349 shares sold in the price range of $41.00 to $41.50 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is April 1, 2014. This option was fully vested as of April 1, 2018.
Billionaire Hedge Funds
